These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11797507)

  • 21. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
    Jackson RS; Schlarman TC; Hubble WL; Osman MM
    J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.
    Kurokawa T; Yoshida Y; Kawahara K; Tsuchida T; Okazawa H; Fujibayashi Y; Yonekura Y; Kotsuji F
    Int J Cancer; 2004 May; 109(6):926-32. PubMed ID: 15027127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region.
    Hany TF; Gharehpapagh E; Kamel EM; Buck A; Himms-Hagen J; von Schulthess GK
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1393-8. PubMed ID: 12271425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy.
    Dizendorf EV; Baumert BG; von Schulthess GK; Lütolf UM; Steinert HC
    J Nucl Med; 2003 Jan; 44(1):24-9. PubMed ID: 12515872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?
    Yap CS; Schiepers C; Fishbein MC; Phelps ME; Czernin J
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1166-73. PubMed ID: 12192561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
    Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
    Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
    Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU
    Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence.
    Metser U; Miller E; Lerman H; Even-Sapir E
    AJR Am J Roentgenol; 2007 Nov; 189(5):1203-10. PubMed ID: 17954662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT.
    Truong MT; Erasmus JJ; Munden RF; Marom EM; Sabloff BS; Gladish GW; Podoloff DA; Macapinlac HA
    AJR Am J Roentgenol; 2004 Oct; 183(4):1127-32. PubMed ID: 15385319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of FDG-PET in the assessment of survival prognosis in melanoma.
    Pleiss C; Risse JH; Biersack HJ; Bender H
    Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Method for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PET.
    Williams G; Kolodny GM
    AJR Am J Roentgenol; 2008 May; 190(5):1406-9. PubMed ID: 18430862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of aging effects upon global knee inflammation by 18F-FDG-PET.
    Saboury B; Parsons MA; Moghbel M; Rubello D; Brothers A; Torigian DA; Werner TJ; Houshmand S; Basu S; Lam MG; Alavi A
    Nucl Med Commun; 2016 Mar; 37(3):254-8. PubMed ID: 26555103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
    Zhuang H; Pourdehnad M; Lambright ES; Yamamoto AJ; Lanuti M; Li P; Mozley PD; Rossman MD; Albelda SM; Alavi A
    J Nucl Med; 2001 Sep; 42(9):1412-7. PubMed ID: 11535734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
    Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
    J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation.
    van Tol KM; Jager PL; Piers DA; Pruim J; de Vries EG; Dullaart RP; Links TP
    Thyroid; 2002 May; 12(5):381-7. PubMed ID: 12097198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased 18F-FDG uptake suggests synovial inflammatory reaction with osteoarthritis: preliminary in-vivo results in humans.
    Parsons MA; Moghbel M; Saboury B; Torigian DA; Werner TJ; Rubello D; Basu S; Alavi A
    Nucl Med Commun; 2015 Dec; 36(12):1215-9. PubMed ID: 26367212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.
    Shreve PD; Anzai Y; Wahl RL
    Radiographics; 1999; 19(1):61-77; quiz 150-1. PubMed ID: 9925392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma.
    Tatsumi M; Kitayama H; Sugahara H; Tokita N; Nakamura H; Kanakura Y; Nishimura T
    J Nucl Med; 2001 Apr; 42(4):601-8. PubMed ID: 11337549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.